These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20133917)

  • 1. Years of disability-adjusted life gained as a result of thrombolytic therapy for acute ischemic stroke.
    Hong KS; Saver JL
    Stroke; 2010 Mar; 41(3):471-7. PubMed ID: 20133917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proof of concept study: relating infarct location to stroke disability in the NINDS rt-PA trial.
    Phan TG; Demchuk A; Srikanth V; Silver B; Patel SC; Barber PA; Levine SR; Hill MD
    Cerebrovasc Dis; 2013; 35(6):560-5. PubMed ID: 23838753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The totaled health risks in vascular events (THRIVE) score predicts ischemic stroke outcomes independent of thrombolytic therapy in the NINDS tPA trial.
    Kamel H; Patel N; Rao VA; Cullen SP; Faigeles BS; Smith WS; Flint AC
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1111-6. PubMed ID: 23122722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group.
    Kwiatkowski TG; Libman RB; Frankel M; Tilley BC; Morgenstern LB; Lu M; Broderick JP; Lewandowski CA; Marler JR; Levine SR; Brott T
    N Engl J Med; 1999 Jun; 340(23):1781-7. PubMed ID: 10362821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality adjusted life year gains associated with administration of recombinant tissue-type plasminogen activator for treatment of acute ischemic stroke: 1998-2011.
    Lubeck DP; Danese MD; Duryea J; Halperin M; Tayama D; Yu E; Lalla D; Grotta JC
    Int J Stroke; 2016 Feb; 11(2):198-205. PubMed ID: 26783311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
    National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group
    Ann Emerg Med; 2005 Sep; 46(3):243-52. PubMed ID: 16126134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case-controlled comparison of thrombolysis outcomes between wake-up and known time of onset ischemic stroke patients.
    Manawadu D; Bodla S; Jarosz J; Keep J; Kalra L
    Stroke; 2013 Aug; 44(8):2226-31. PubMed ID: 23723307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study.
    Kwiatkowski T; Libman R; Tilley BC; Lewandowski C; Grotta JC; Lyden P; Levine SR; Brott T;
    Ann Emerg Med; 2005 Apr; 45(4):377-84. PubMed ID: 15795715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of age on outcome from thrombolysis in acute stroke: a controlled comparison in patients from the Virtual International Stroke Trials Archive (VISTA).
    Mishra NK; Diener HC; Lyden PD; Bluhmki E; Lees KR;
    Stroke; 2010 Dec; 41(12):2840-8. PubMed ID: 21030710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time trends in systemic thrombolysis in a large hospital-based stroke registry.
    Singer OC; Hamann GF; Misselwitz B; Steinmetz H; Foerch C;
    Cerebrovasc Dis; 2012; 33(4):316-21. PubMed ID: 22343969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolytic therapy with intravenous recombinant tissue plasminogen activator in Japanese older patients with acute ischemic stroke: Fukuoka Stroke Registry.
    Matsuo R; Kamouchi M; Ago T; Hata J; Shono Y; Kuroda J; Wakisaka Y; Sugimori H; Kitazono T;
    Geriatr Gerontol Int; 2014 Oct; 14(4):954-9. PubMed ID: 24320947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic thrombolysis in patients with acute ischemic stroke and Internal Carotid ARtery Occlusion: the ICARO study.
    Paciaroni M; Balucani C; Agnelli G; Caso V; Silvestrelli G; Grotta JC; Demchuk AM; Sohn SI; Orlandi G; Leys D; Pezzini A; Alexandrov AV; Silvestrini M; Fofi L; Barlinn K; Inzitari D; Ferrarese C; Tassi R; Tsivgoulis G; Consoli D; Baldi A; Bovi P; Luda E; Galletti G; Invernizzi P; DeLodovici ML; Corea F; Del Sette M; Monaco S; Marcheselli S; Alberti A; Venti M; Acciarresi M; D'Amore C; Macellari F; Lanari A; Previdi P; Gonzales NR; Pandurengan RK; Vahidy FS; Sline M; Bal SS; Chiti A; Gialdini G; Dumont F; Cordonnier C; Debette S; Padovani A; Cerqua R; Bodechtel U; Kepplinger J; Nesi M; Nencini P; Beretta S; Trentini C; Martini G; Piperidou C; Heliopoulos I; D'Anna S; Cappellari M; Donati E; Bono G; Traverso E; Toni D
    Stroke; 2012 Jan; 43(1):125-30. PubMed ID: 22034003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study.
    Paciaroni M; Agnelli G; Caso V; Pieroni A; Bovi P; Cappellari M; Zini A; Nichelli P; Inzitari D; Nesi M; Nencini P; Pezzini A; Padovani A; Tassinari T; Orlandi G; Chiti A; Gialdini G; Alberti A; Venti M; Acciarresi M; D'Amore C; Luda E; Tassi R; Martini G; Ferrarese C; Beretta S; Trentini C; Silvestrelli G; Lanari A; Previdi P; Ciccone A; Delodovici ML; Bono G; Galletti G; Marcheselli S; Del Sette M; Traverso E; Riva M; Silvestrini M; Cerqua R; Consoli D; Monaco S; Toni D
    Cerebrovasc Dis; 2012; 34(5-6):430-5. PubMed ID: 23207482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Years of optimum health lost due to complications after acute ischemic stroke: disability-adjusted life-years analysis.
    Hong KS; Saver JL; Kang DW; Bae HJ; Yu KH; Koo J; Han MK; Cho YJ; Park JM; Lee BC
    Stroke; 2010 Aug; 41(8):1758-65. PubMed ID: 20595674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.
    Sahlas DJ; Gould L; Swartz RH; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):155-9. PubMed ID: 23375748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transition of European Cooperative Acute Stroke Study III results to clinical practice: ninety-day outcomes in a US cohort.
    Cronin CA; Langenberg P; Dutta TM; Kittner SJ
    Stroke; 2013 Dec; 44(12):3544-6. PubMed ID: 24092551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic therapy for stroke in patients with preexisting cognitive impairment.
    Murao K; Leys D; Jacquin A; Kitazono T; Bordet R; Béjot Y; Kimura K; Godefroy O; Wakisaka Y; Moulin S; Ago T; Sibon I; Bombois S; Mas JL; Hénon H; Pasquier F; Giroud M; Cordonnier C; Okada Y;
    Neurology; 2014 Jun; 82(23):2048-54. PubMed ID: 24827495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting neuroprotection clinical trials to ischemic stroke patients with potential to benefit from therapy.
    Weir CJ; Kaste M; Lees KR;
    Stroke; 2004 Sep; 35(9):2111-6. PubMed ID: 15243146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endovascular therapy for ischemic stroke: Save a minute-save a week.
    Meretoja A; Keshtkaran M; Tatlisumak T; Donnan GA; Churilov L
    Neurology; 2017 May; 88(22):2123-2127. PubMed ID: 28455382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.